Symbols

GENB

Generate Biomedicines·NASDAQ

--(--)

3.98 / 10

Netural

Fund flow is rated good (7.95/10) with positive inflows across all investor sizes. Analysts are 40% Strong Buy and 60% Buy, yet all have zero historical win rates and the price fell 4.35%. Market sentiment is neutral, implying mixed confidence.

Fund Flow Rating

Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

40%

Buy

60%

Hold

Sell

Strong Sell

Date2026-03-24

InstitutionPiper Sandler

Times predicted1

Historical Win Rate0.0%

Is money flowing into or out of GENB?

GENB holds a Bearish analyst rating, with 60% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.98/10 (Netural).